Cargando…
Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges
Breast cancer therapeutic intervention continues to be ambiguous owing to the lack of strategies for targeted transport and receptor-mediated uptake of drugs by cancer cells. In addition to this, sporadic tumor microenvironment, prominent restrictions with conventional chemotherapy, and multidrug-re...
Autores principales: | Rizwanullah, Md., Ahmad, Mohammad Zaki, Ghoneim, Mohammed M., Alshehri, Sultan, Imam, Syed Sarim, Md, Shadab, Alhakamy, Nabil A., Jain, Keerti, Ahmad, Javed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708551/ https://www.ncbi.nlm.nih.gov/pubmed/34959321 http://dx.doi.org/10.3390/pharmaceutics13122039 |
Ejemplares similares
-
Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges
por: Alshehri, Sultan, et al.
Publicado: (2020) -
Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives
por: Imam, Syed Sarim, et al.
Publicado: (2021) -
Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments
por: Rahat, Iqra, et al.
Publicado: (2021) -
Nanogels as Potential Delivery Vehicles in Improving the Therapeutic Efficacy of Phytopharmaceuticals
por: Taha, Murtada, et al.
Publicado: (2022) -
Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges
por: Bukhari, Sarah I., et al.
Publicado: (2021)